LBT has potential but FDA approvals are way overhyped until you can demonstrate sales ability. I'd be more excited to hear about more sales in Aus or Europe rather than this announcement.
Everyone thinks healthcare stocks are about having strong evidence and regulatory approvals but in most cases, your ability to sell and get traction is what counts... IMHO.
I was surprised at the massive jump today.
Ann: APAS Independence Receives US FDA 510(k) Clearance, page-117
-
- There are more pages in this discussion • 266 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.002(9.38%) |
Mkt cap ! $23.47M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $38.2K | 2.526M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1719439 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1133000 | 4 |
View Market Depth
| Last trade - 14.29pm 19/08/2024 (20 minute delay) ? |
| LBT (ASX) Chart |